Molecular Products Group
Founded Year
1924Stage
Acq - Fin | AliveTotal Raised
$6.55MAbout Molecular Products Group
Molecular Products is a manufacturer of advanced chemistry-based products serving the healthcare, defense, and industrial markets. The Company primarily specializes in the manufacture and supply of chemical technologies for the treatment of breathable gases and is able to serve its customer base out of its two primary manufacturing facilities in Harlow, Essex, U.K. and Boulder, CO.
Molecular Products Group Headquarter Location
Parkway, Harlow Business Park Harlow
Essex, England, CM19 5FR,
United Kingdom
+44 (0)1279 445111
Expert Collections containing Molecular Products Group
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Molecular Products Group is included in 2 Expert Collections, including Medical Devices.
Medical Devices
7,909 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health IT
7,900 items
Molecular Products Group Patents
Molecular Products Group has filed 3 patents.
Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
12/11/2014 | 11/6/2018 | Industrial gases, Gas technologies, Oxidizing agents, Chemical processes, Diving medicine | Grant |
Application Date | 12/11/2014 |
---|---|
Grant Date | 11/6/2018 |
Title | |
Related Topics | Industrial gases, Gas technologies, Oxidizing agents, Chemical processes, Diving medicine |
Status | Grant |
Latest Molecular Products Group News
Nov 4, 2019
Lugo Company. Lugo Company, located in Connellsville, PA, manufactures sodium chlorate-based chemical oxygen generators, and is a prime contractor for the United States Navy. Chemical oxygen generators are devices used to produce pure, breathable oxygen for use in enclosed spaces, including submarines. Troy Rhudy, CEO of the Molecular Products Group, said, “As the world leader in chemical oxygen generation systems, Molecular Products is excited to welcome the O.C. Lugo Company into the Group. Our combined capabilities will support our continued growth in the defense industry while strengthening our service to our global customer base.” “The acquisition of the O.C. Lugo Company demonstrates Molecular Products’ continued investment in its market-leading chemical oxygen generation franchise. The transaction expands the Company’s product offerings and provides another key chemical oxygen generator manufacturing site in addition to our existing capacity in Harlow, England and in our state-of-the-art Louisville, CO facility,” said Peter Manos, a Managing Partner at Arlington Capital Partners. Malcolm Little, a Partner at Arlington Capital, added, “This is Molecular Products’ second strategic acquisition in the last twelve months. We are very excited for the tremendous growth opportunities these highly complementary acquisitions bring in each of Molecular Products’ core markets.” About Molecular Products Molecular Products is a Pure Air Technologies company and leading manufacturer of advanced chemistry-based products serving the healthcare, defense and industrial markets. The Company specializes in the manufacture and supply of chemical technologies for the treatment of breathable gases and serves its global customer base out of its two primary manufacturing facilities in Louisville, Colorado, USA and Harlow, Essex, UK. About Arlington Capital Partners Arlington Capital Partners is a Washington, D.C.-area private equity firm that has managed $4.0 billion of committed capital via five investment funds. Arlington Capital is focused on middle market investment opportunities in growth industries, including: aerospace/defense, government services and technology, healthcare, and business services and software. The firm’s professionals and network have a unique combination of operating and private equity experience that enable Arlington Capital to be a value-added investor. Arlington Capital invests in companies in partnership with high quality management teams that are motivated to establish and/or advance their company’s position as leading competitors in their field. www.arlingtoncap.com Contacts
Molecular Products Group Web Traffic
Molecular Products Group Rank
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.